In view of the increasing importance of real-world data, we have been developing and validating our CHDR MORE® wearables/home monitoring platform. We are therefore very excited about our new collaboration with Facio Therapies, which is aimed at validating CHDR MORE® as a clinical outcome measure for FSHD patients.
Read Facio's full press release on our research agreement here
